ARCHIVES

Velcade Improves Survival In Relapsed Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 20, 2002

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

NCI to set separate payline for R01s over $700,000.

February 13, 2004

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002